{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:13:37Z","timestamp":1759335217832,"version":"3.44.0"},"reference-count":17,"publisher":"BMJ","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ Case Reports"],"abstract":"<jats:p>Intravenous immunoglobulin (IVIg) treatment is highly effective for autoimmune diseases including myasthenia gravis. Recovery is observed at approximately. 75% of myasthenia gravis patients through IVIg treatment. As a result of many clinical studies, the recommended dose is determined as 0.4\u2005g\/kg for 5\u2005days (maximum total dose at 2\u2005g\/kg body weight). If an additional immunomodulatory treatment is not administered, IVIg maintenance treatment is needed mostly. However, some side effects may inhibit long-term treatment. For this reason, it is important to know the effect profile well and when the treatment should be discontinued. A female myasthenia gravis patient case is presented here, where dyshidrotic eczema has occurred after the second dose of \u00a0intravenous Ig medication and whose treatment is despite further IVIg therapy.<\/jats:p>","DOI":"10.1136\/bcr-2012-008001","type":"journal-article","created":{"date-parts":[[2013,2,15]],"date-time":"2013-02-15T23:31:53Z","timestamp":1360971113000},"page":"bcr2012008001","source":"Crossref","is-referenced-by-count":9,"title":["Dyshidrotic eczema associated with the use of IVIg"],"prefix":"10.1136","volume":"2013","author":[{"given":"Dilcan","family":"Kotan","sequence":"first","affiliation":[{"name":"Department of Neurology, Sakarya University Faculty of Medicine, Sakarya, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teoman","family":"Erdem","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Sakarya University Faculty of Medicine, Sakarya, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilgehan Atilgan","family":"Acar","sequence":"additional","affiliation":[{"name":"Department of Neurology, SB Sakarya University Education and Research Hospital, Sakarya, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayhan","family":"Boluk","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sakarya University Faculty of Medicine, Sakarya, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2013,2,15]]},"reference":[{"key":"2025082722162384000_2013.feb15_1.bcr2012008001.1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-007-9088-9"},{"key":"2025082722162384000_2013.feb15_1.bcr2012008001.2","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0140-6736(81)92400-4","article-title":"High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood","volume":"6","author":"Imbach","year":"1981","journal-title":"Lancet"},{"key":"2025082722162384000_2013.feb15_1.bcr2012008001.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2007.01.002"},{"key":"2025082722162384000_2013.feb15_1.bcr2012008001.4","doi-asserted-by":"publisher","DOI":"10.1080\/08916930500059633"},{"key":"2025082722162384000_2013.feb15_1.bcr2012008001.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1741-6892.2004.00475.x"},{"key":"2025082722162384000_2013.feb15_1.bcr2012008001.6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2005.02834.x"},{"key":"2025082722162384000_2013.feb15_1.bcr2012008001.7","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1212\/WNL.53.5.1154","article-title":"Pompholyx (vesicular eczema) after IV immunoglobulin therapy for neurologic disease","volume":"53","author":"Iannaccone","year":"1999","journal-title":"Neurology"},{"key":"2025082722162384000_2013.feb15_1.bcr2012008001.8","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2003.00239.x"},{"key":"2025082722162384000_2013.feb15_1.bcr2012008001.9","unstructured":"Aminoff MJ , ed. Neurology and general medicine. 4th edn. Philadelphia: Churchill Livingstone Elsevier, 2008."},{"key":"2025082722162384000_2013.feb15_1.bcr2012008001.10","first-page":"416","article-title":"Use of immunoglobulins in adults in a university hospital: a retrospective study","volume":"66","author":"Farber","year":"2011","journal-title":"Acta Clin Belg"},{"key":"2025082722162384000_2013.feb15_1.bcr2012008001.11","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2165\/00002018-199309040-00003","article-title":"Adverse effects of intravenous immunoglobulin","volume":"9","author":"Misbah","year":"1993","journal-title":"Drug Saf"},{"key":"2025082722162384000_2013.feb15_1.bcr2012008001.12","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.2002.01545.x"},{"key":"2025082722162384000_2013.feb15_1.bcr2012008001.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra993360"},{"key":"2025082722162384000_2013.feb15_1.bcr2012008001.14","doi-asserted-by":"crossref","first-page":"418","DOI":"10.12968\/bjcn.2011.16.9.418","article-title":"Eczema diagnosis and management in the community","volume":"16","author":"Watkins","year":"2011","journal-title":"Br J Community Nurs"},{"key":"2025082722162384000_2013.feb15_1.bcr2012008001.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.12.034"},{"key":"2025082722162384000_2013.feb15_1.bcr2012008001.16","doi-asserted-by":"crossref","unstructured":"Shiraishi T Yamamoto T . Severe dyshidrotic eczema after intravenous immunoglobulin therapy for Kawasaki syndrome. Pediatr Dermatol 2012. doi:10.1111\/j.1525\u20131470.2011.01717.x. (Epub ahead of print).","DOI":"10.1111\/j.1525-1470.2011.01717.x"},{"key":"2025082722162384000_2013.feb15_1.bcr2012008001.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.09.042"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2012-008001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T05:16:32Z","timestamp":1756358192000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2012-008001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,15]]},"references-count":17,"alternative-id":["10.1136\/bcr-2012-008001"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2012-008001","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2013,2,15]]}}}